The post Fifth XRP ETF Set to Debut After Cboe Approval appeared on BitcoinEthereumNews.com. Altcoins Momentum around U.S. XRP investment products is accelerating once again, with a new exchange-traded fund preparing to enter the market after clearing a major regulatory hurdle. The Cboe has granted approval for 21Shares’ planned XRP product, bringing a fresh entrant into a category that has already attracted hundreds of millions of dollars in capital. Key Takeaways 21Shares received Cboe approval to list its XRP ETF under the ticker TOXR. Ripple Markets seeded the fund with 100 million XRP to support early liquidity. U.S. XRP ETFs have attracted nearly $1 billion in inflows with no outflow days so far. Instead of arriving with a large public announcement, the update surfaced through a regulatory filing confirming that the upcoming fund — which will trade under the ticker TOXR – is now eligible for listing once final procedural steps are completed. The approval effectively positions TOXR to join a growing cluster of XRP-linked ETFs that have launched in rapid succession over recent weeks. How the TOXR Product Is Structured The 21Shares fund will be modeled on the CME CF XRP-Dollar Reference Rate used by institutional benchmarks, giving traders a regulated way to follow XRP’s performance without having to secure or store the asset themselves. TOXR’s cost structure includes a 0.3 percent annual sponsor fee, calculated daily and settled weekly in XRP. To support liquidity from day one, Ripple Markets has already contributed 100 million XRP, roughly valued at $226 million, ensuring a deep pool for creations and redemptions. These processes can be executed either through direct XRP transfers or cash-based mechanisms, depending on participant preference. The approval follows several amendments to 21Shares’ S-1 filing, which the issuer updated repeatedly this month as it prepared the product for launch. XRP ETFs Are Posting Remarkable Early Demand While the new fund prepares to go… The post Fifth XRP ETF Set to Debut After Cboe Approval appeared on BitcoinEthereumNews.com. Altcoins Momentum around U.S. XRP investment products is accelerating once again, with a new exchange-traded fund preparing to enter the market after clearing a major regulatory hurdle. The Cboe has granted approval for 21Shares’ planned XRP product, bringing a fresh entrant into a category that has already attracted hundreds of millions of dollars in capital. Key Takeaways 21Shares received Cboe approval to list its XRP ETF under the ticker TOXR. Ripple Markets seeded the fund with 100 million XRP to support early liquidity. U.S. XRP ETFs have attracted nearly $1 billion in inflows with no outflow days so far. Instead of arriving with a large public announcement, the update surfaced through a regulatory filing confirming that the upcoming fund — which will trade under the ticker TOXR – is now eligible for listing once final procedural steps are completed. The approval effectively positions TOXR to join a growing cluster of XRP-linked ETFs that have launched in rapid succession over recent weeks. How the TOXR Product Is Structured The 21Shares fund will be modeled on the CME CF XRP-Dollar Reference Rate used by institutional benchmarks, giving traders a regulated way to follow XRP’s performance without having to secure or store the asset themselves. TOXR’s cost structure includes a 0.3 percent annual sponsor fee, calculated daily and settled weekly in XRP. To support liquidity from day one, Ripple Markets has already contributed 100 million XRP, roughly valued at $226 million, ensuring a deep pool for creations and redemptions. These processes can be executed either through direct XRP transfers or cash-based mechanisms, depending on participant preference. The approval follows several amendments to 21Shares’ S-1 filing, which the issuer updated repeatedly this month as it prepared the product for launch. XRP ETFs Are Posting Remarkable Early Demand While the new fund prepares to go…